Literature DB >> 25716483

The neuropsychiatric spectrum of motivational disorders.

Jane Epstein1, David Silbersweig.   

Abstract

Adaptive behavior requires neural systems that mediate the evaluation of stimuli in terms of the well-being of the organism and generate subsequent goal-directed behavior. The authors provide an overview of these systems, with an emphasis on those related to positive motivation/approach. The authors outline the contributions of various disciplines to the current understanding of these systems and discuss their dysfunction in the context of multiple neuropsychiatric disorders in terms of deficits, dysregulation, excess, and related syndromes. Illustrative examples are provided, with an emphasis on functional neuroimaging studies. This approach can provide a foundation for conceptualization, diagnosis, and targeted neuromodulatory therapeutics of neuropsychiatric disorders.

Entities:  

Mesh:

Year:  2015        PMID: 25716483     DOI: 10.1176/appi.neuropsych.13120370

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  7 in total

Review 1.  A Primer on Foraging and the Explore/Exploit Trade-Off for Psychiatry Research.

Authors:  M A Addicott; J M Pearson; M M Sweitzer; D L Barack; M L Platt
Journal:  Neuropsychopharmacology       Date:  2017-05-29       Impact factor: 7.853

2.  The influence of reinforcement schedule on experience-dependent changes in motivation.

Authors:  Amy R Johnson; Brooke A Christensen; Shannon J Kelly; Erin S Calipari
Journal:  J Exp Anal Behav       Date:  2022-03-28       Impact factor: 2.215

Review 3.  Rat models of reward deficits in psychiatric disorders.

Authors:  Chloe L Slaney; Claire A Hales; Emma S J Robinson
Journal:  Curr Opin Behav Sci       Date:  2018-08

4.  Glutamine-to-glutamate ratio in the nucleus accumbens predicts effort-based motivated performance in humans.

Authors:  Alina Strasser; Gediminas Luksys; Lijing Xin; Mathias Pessiglione; Rolf Gruetter; Carmen Sandi
Journal:  Neuropsychopharmacology       Date:  2020-07-20       Impact factor: 7.853

Review 5.  Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.

Authors:  Gregory P Strauss; Lisa A Bartolomeo; Philip D Harvey
Journal:  NPJ Schizophr       Date:  2021-02-26

6.  S-Equol mitigates motivational deficits and dysregulation associated with HIV-1.

Authors:  Kristen A McLaurin; Sarah J Bertrand; Jessica M Illenberger; Steven B Harrod; Charles F Mactutus; Rosemarie M Booze
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

7.  Opposite effects of stress on effortful motivation in high and low anxiety are mediated by CRHR1 in the VTA.

Authors:  Ioannis Zalachoras; Simone Astori; Mandy Meijer; Jocelyn Grosse; Olivia Zanoletti; Isabelle Guillot de Suduiraut; Jan M Deussing; Carmen Sandi
Journal:  Sci Adv       Date:  2022-03-23       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.